Correlation of the intrinsic clearance of donepezil (Aricept) between in vivo and in vitro studies in rat, dog and human.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Xenobiotica; the fate of foreign compounds in biological systems

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1080/004982599237958PMID 10598742
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vivo pharmacokinetics of felodipine predicted from in vitro studies in rat, dog and man.

  2009cited by this paper
• Absorption, distribution, metabolism, and excretion of donepezil (Aricept) after a single oral administration to Rat.

  1999cited by this paper
• Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group.

  1998cited by this paper
• Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance.

  1994cited by this paper
• Metabolism: Scaling-up from In Vitro to Organ and Whole Body

  1994cited by this paper
• Pharmacokinetic correlation between in vitro hepatic microsomal enzyme kinetics and in vivo metabolism of imipramine and desipramine in rats.

  1990cited by this paper
• Kinetic properties of the metabolism of imipramine and desipramine in isolated rat hepatocytes.

  1990cited by this paper
• Clinical applicability of current pharmacokinetic models: Splanchnic elimination of 5-fluorouracil in cancer patients

  1988cited by this paper
• Clearance approaches in pharmacology.

  1987cited by this paper
• A dispersion model of hepatic elimination: 3. Application to metabolite formation and elimination kinetics

  1986cited by this paper
• A dispersion model of hepatic elimination: 1. Formulation of the model and bolus considerations

  1986cited by this paper
• Problems in Correlating In Vitro and In Vivo Studies of Drug Metabolism

  1984cited by this paper
• Physiological pharmacokinetics of ethoxybenzamide based on biochemical data obtainedin vitro as well as on physiological data

  1982cited by this paper
• A pharmacokinetic analysis program (multi) for microcomputer.

  1981cited by this paper
• Interspecies variation in liver weight, hepatic blood flow, and antipyrine intrinsic clearance: Extrapolation of data to benzodiazepines and phenytoin

  1980cited by this paper
• Correlation betweenin vitro andin vivo drug metabolism rate: Oxidation of ethoxybenzamide in rat

  1978cited by this paper
• Hepatic clearance of drugs. III. Additional experimental evidence supporting the “wellstirred” model, using metabolite (MEGX) generated from lidocaine under varying hepatic blood flow rates and linear conditions in the perfused rat liverin situ preparation

  1977cited by this paper
• Cytochrome P-450 measurement in rat liver homogenate and microsomes. Its use for correction of microsomal losses incurred by differential centrifugation.

  1975cited by this paper
• Commentary: a physiological approach to hepatic drug clearance.

  1975cited by this paper
• Effects of lyophilization and storage of rat liver microsomes on activity of aniline hydroxylase, contents of cytochrome b5 and cytochrome p-450 and aniline-induced p-450 difference spectrum.

  1974cited by this paper
• Clearance concepts in pharmacokinetics

  1973cited by this paper
• Transport and binding of methotrexate in vivo.

  1973cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Pharmacokinetic/Pharmacodynamic Models of an Alzheimer’s Drug, Donepezil, in Rats

  2022influential citation
• The Impact of Dextran Sodium Sulfate-Induced Gastrointestinal Injury on the Pharmacokinetic Parameters of Donepezil and Its Active Metabolite 6-O-desmethyldonepezil, and Gastric Myoelectric Activity in Experimental Pigs

  2021cites this paper
• Long-acting injectable donepezil microspheres: Formulation development and evaluation.

  2021cites this paper
• Gene Polymorphisms Affecting the Pharmacokinetics and Pharmacodynamics of Donepezil Efficacy

  2020cites this paper
• Alzheimer’s Disease Pharmacotherapy in Relation to Cholinergic System Involvement

  2019cites this paper
• The Aged Dog as a Natural Model of Alzheimer’s Disease Progression

  2017cites this paper
• Canine and Feline Dementia

  2017cites this paper
• Stereoselective metabolism of donepezil and steady-state plasma concentrations of S-donepezil based on CYP2D6 polymorphisms in the therapeutic responses of Han Chinese patients with Alzheimer's disease.

  2015cites this paper
• Pharmacokinetic and pharmacodynamic evaluation of donepezil for the treatment of Alzheimer's disease

  2014cites this paper
• Drug Response Heterogeneity and the Genetic Variability of Cytochrome P450–Metabolizing Enzymes

  2014cites this paper
• Biomarkers for metabolic drug activation : towards an integrated risk assessment for drug-induced liver injury (DILI)

  2014cites this paper
• A novel electronic skin patch for delivery and pharmacokinetic evaluation of donepezil following transdermal iontophoresis.

  2013cites this paper
• Pharmacodynamic, Pharmacokinetic and Pharmacogenetic Aspects of Drugs Used in the Treatment of Alzheimer’s Disease

  2013cites this paper
• Dried Blood Spot Analysis of Donepezil in Support of a GLP 3-month Dose-Range Finding Study in Rats

  2012cites this paper
• Absorption, Distribution and Excretion Pattern of Oral and Transdermal Donepezil Hydrochloride after Single and Repeated Administration to the Rat

  2012cites this paper
• Comparison of Metabolism of Donepezil in Rat, Mini-Pig and Human, Following Oral and Transdermal Administration, and in an In Vitro Model of Human Epidermis

  2012cites this paper
• Prediction of human renal clearance from preclinical species for a diverse set of drugs that exhibit both active secretion and net re-absorption

  2011cites this paper
• Prediction of Human Renal Clearance from Preclinical Species for a Diverse Set of Drugs That Exhibit Both Active Secretion and Net Reabsorption

  2011cites this paper
• Cholinesterase Inhibitors Improve Both Memory and Complex Learning in Aged Beagle Dogs

  2011cites this paper
• Prediction of human renal clearance from preclinical species for a diverse set of drugs that exhibit both active secretion and net re-absorption

  2011cites this paper
• Evidence of carrier-mediated transport in the penetration of donepezil into the rat brain.

  2010cites this paper
• Substrate specificity, inhibitors and regulation of human cytochrome P450 2D6 and implications in drug development.

  2009cites this paper
• Polymorphism of human cytochrome P450 enzymes and its clinical impact

  2009influential citation
• Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development.

  2009cites this paper
• Synthetic and natural compounds that interact with human cytochrome P450 1A2 and implications in drug development.

  2009cites this paper
• Prediction of human pharmacokinetics—evaluation of methods for prediction of hepatic metabolic clearance

  2007cites this paper
• The combination of donepezil and procyclidine protects against soman-induced seizures in rats.

  2007cites this paper
• Therapeutic options for cognitive decline in senior pets.

  2006cites this paper
• Chapter 10 Oxidative metabolites of drugs and xenobiotics: lc-ms methods to identify and characterize in biological matrices

  2005cites this paper
• Drug metabolism and drug interactions: application and clinical value of in vitro models.

  2003cites this paper
• Prediction of human pharmacokinetics from animal data and molecular structural parameters using multivariate regression analysis: oral clearance.

  2003cites this paper
• Incorporating measures of variability and uncertainty into the prediction of in vivo hepatic clearance from in vitro data.

  2002cites this paper
• The use of in vitro methods to predict in vivo pharmacokinetics and drug interactions.

  2001cites this paper
• Steroid hormones mediate sex difference in brain levels of tacrine and its hypothermic effect in the rat.

  2001cites this paper
• Chapter 27. Ex vivo approaches to predicting oral pharmacokinetics in humans

  2000cites this paper
• Identification of Cytochrome P450 Involved in the Metabolism of Donepezil and In Vitro Drug Interaction Study in Human Liver Microsomes

  2000cites this paper